The CVMap® test is a next-generation cardiovascular assessment that goes far beyond the standard cholesterol panel. By integrating traditional lipid markers with advanced biomarkers for inflammation, oxidative stress, and cholesterol metabolism, this test offers a full-spectrum view of your heart health. It helps identify risks that standard blood tests often miss, empowering patients and providers to take more precise, personalized action.

Rather than focusing solely on total cholesterol or LDL levels, CVMap® evaluates the quality and behavior of lipids in the body—giving you a deeper understanding of cardiovascular function, arterial inflammation, and metabolic efficiency.

• Key features:

  • Standard lipid panel, plus LDL particle number and ApoB—a more accurate predictor of cardiovascular events

  
  • Lipoprotein(a) [Lp(a)]—a genetic marker linked to elevated heart disease and stroke risk

  
  • Inflammatory markers including hs-CRP, MPO, and LpPLA2 activity

  • Cholesterol Balance®—insight into whether your body tends to absorb or synthesize more cholesterol

• Ideal for individuals who:
  • Are starting or reevaluating cholesterol-lowering therapy

  
  • Have a personal or family history of early heart disease or stroke

  
  • Want a more detailed, proactive approach to preventive cardiovascular care